Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gisselsson

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Advances in Cancer Research|September 20, 2011
Intratumor diversity and clonal evolution in cancer--a skeptical standpointDavid Gisselsson
Cell Cycle (Georgetown, Tex.)|January 15, 2011
Aneuploidy in cancer: sudden or sequential?David Gisselsson
Seminars in Cancer Biology|June 30, 2006
Cancer stem cells: differentiation block or developmental back-tracking?David Gisselsson
Chromosoma|June 6, 2008
Classification of chromosome segregation errors in cancerDavid Gisselsson
Advances in Cancer Research|March 19, 2003
Chromosome instability in cancer: how, when, and why?David Gisselsson
Health Security|January 13, 2022
Next-Generation Biowarfare: Small in Scale, Sensational in Nature?David Gisselsson
Cell Cycle (Georgetown, Tex.)|August 6, 2005
Mitotic instability in cancer: is there method in the madness?David Gisselsson
Cancer Reports (Hoboken, N.J.)|May 1, 2021
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?Anders Valind, David Gisselsson
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2014
Reply to Heng: Inborn aneuploidy and chromosomal instabilityAnders Valind, David Gisselsson
Trends in Cancer|July 3, 2023
Wargaming cancer: a strategy for future precision oncology?Tony Ingesson, David Gisselsson
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Advances in Cancer Research|September 20, 2011
Intratumor diversity and clonal evolution in cancer--a skeptical standpointDavid Gisselsson
Cell Cycle (Georgetown, Tex.)|January 15, 2011
Aneuploidy in cancer: sudden or sequential?David Gisselsson
Seminars in Cancer Biology|June 30, 2006
Cancer stem cells: differentiation block or developmental back-tracking?David Gisselsson
Chromosoma|June 6, 2008
Classification of chromosome segregation errors in cancerDavid Gisselsson
Advances in Cancer Research|March 19, 2003
Chromosome instability in cancer: how, when, and why?David Gisselsson
Health Security|January 13, 2022
Next-Generation Biowarfare: Small in Scale, Sensational in Nature?David Gisselsson
Cell Cycle (Georgetown, Tex.)|August 6, 2005
Mitotic instability in cancer: is there method in the madness?David Gisselsson
Cancer Reports (Hoboken, N.J.)|May 1, 2021
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?Anders Valind, David Gisselsson
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2014
Reply to Heng: Inborn aneuploidy and chromosomal instabilityAnders Valind, David Gisselsson
Trends in Cancer|July 3, 2023
Wargaming cancer: a strategy for future precision oncology?Tony Ingesson, David Gisselsson
Pageof 15